Efficacy of tolterodine as a first-line treatment for non-neurogenic voiding dysfunction in children

Semih Ayan1, Kemal Kaya, Kahraman Topsakal

  • 1Department of Urology, Medical Faculty, Cumhuriyet University, Sivas, Turkey. sayan@cumhuriyet.edu.tr

BJU International
|July 27, 2005
PubMed

Insights

First-line treatment with tolterodine and behavioral modification significantly improved symptoms in children with dysfunctional voiding. This approach offers a safe and effective alternative to invasive evaluations for pediatric voiding dysfunction.

Area of Science:

  • Pediatric Urology
  • Pharmacology
  • Behavioral Therapy

Background:

  • Non-neurogenic voiding dysfunction is common in children.
  • Current treatment often involves invasive investigations.
  • A need exists for effective first-line, non-invasive therapies.

Purpose of the Study:

  • To evaluate tolterodine combined with behavioral modification as a first-line treatment for pediatric voiding dysfunction.
  • To assess the efficacy of this combined approach before resorting to invasive evaluations.
  • To determine if this treatment is suitable for children without neurological or anatomical abnormalities.

Main Methods:

  • A study involving 44 children (30 girls, 14 boys) with voiding dysfunction.
  • Noninvasive evaluation including history, urinalysis, and imaging.
  • Treatment with tolterodine (1 mg twice daily) and behavioral modifications (timed voiding, pelvic floor relaxation).
  • Dysfunctional Voiding Symptom Score (DVSS) assessed at baseline and 3 months.

Main Results:

  • The mean DVSS significantly decreased from 14.0 to 6.68 after treatment (P < 0.001).
  • Both girls and boys showed significant improvements in DVSS scores.
  • The treatment was well-tolerated in the pediatric population.

Conclusions:

  • Tolterodine and behavioral modification are effective first-line treatments for pediatric voiding dysfunction.
  • This combined therapy can be recommended before invasive investigations.
  • The DVSS is a reliable tool for monitoring treatment outcomes in children with voiding dysfunction.
Abstract

Related Concept Videos

Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
The Micturition Reflex01:26

The Micturition Reflex

Urination, or micturition involves the coordination of the bladder's detrusor muscle and two sphincters to ensure controlled bladder emptying.
The process begins with bladder filling, where the bladder wall stretches as urine accumulates. This stretching activates the urine storage reflex, mediated by the sacral spinal segments and the pontine storage center. Efferent sympathetic impulses stimulate the detrusor muscle to relax and the internal urethral sphincter to contract, facilitating urine...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Urodynamic Studies: Uroflowmetry01:19

Urodynamic Studies: Uroflowmetry

Uroflowmetry is a non-invasive urodynamic test designed to measure various aspects of urination, including volume, flow rate, and the time to void. This test is crucial for diagnosing and assessing conditions such as bladder outlet obstruction, bladder dysfunction, incomplete bladder emptying, incontinence, and urinary tract blockages caused by benign prostatic hyperplasia (BPH) and urethral strictures.Pre-Test Instructions:Before a uroflowmetry test, patients are typically advised to drink...